Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 3
2002 14
2003 28
2004 34
2005 27
2006 32
2007 31
2008 28
2009 29
2010 34
2011 36
2012 29
2013 28
2014 29
2015 29
2016 9
2017 12
2018 12
2019 6
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

402 results
Results by year
Filters applied: . Clear all
Page 1
Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Babyshkina N, Zavyalova M, Tarabanovskaya N, Dronova T, Krakhmal N, Slonimskaya E, Kzhyshkowska J, Choynzonov E, Cherdyntseva N. Babyshkina N, et al. Mol Cell Biochem. 2018 Jul;444(1-2):197-206. doi: 10.1007/s11010-017-3244-1. Epub 2017 Dec 11. Mol Cell Biochem. 2018. PMID: 29230610 Clinical Trial.
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
Guan J, Darb-Esfahani S, Richter R, Taube ET, Ruscito I, Mahner S, Woelber L, Prieske K, Concin N, Vergote I, Van Nieuwenhuysen E, Achimas-Cadariu P, Glajzer J, Woopen H, Stanske M, Kulbe H, Denkert C, Sehouli J, Braicu EI. Guan J, et al. J Cancer Res Clin Oncol. 2019 Apr;145(4):1063-1073. doi: 10.1007/s00432-019-02877-4. Epub 2019 Feb 27. J Cancer Res Clin Oncol. 2019. PMID: 30810838
Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue.
Bobic S, Hox V, Callebaut I, Vinckier S, Jonckx B, Stassen JM, Jorissen M, Gevaert P, Carmeliet P, Bachert C, Ceuppens JL, Hellings PW. Bobic S, et al. Allergy. 2014 Feb;69(2):237-45. doi: 10.1111/all.12277. Epub 2013 Oct 15. Allergy. 2014. PMID: 24127643
Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors.
Akhavan-Sigari R, Gaab MR, Rohde V, Brandis A, Tezval H, Abili M, von Eckardstein K, Ostertag H. Akhavan-Sigari R, et al. Neurosurg Rev. 2014 Jan;37(1):79-88. doi: 10.1007/s10143-013-0495-5. Epub 2013 Sep 3. Neurosurg Rev. 2014. PMID: 23999886
402 results
Jump to page
Feedback